Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

China · Delayed Price · Currency is CNY

12.72

+0.11 (0.87%)

Jul 3, 2026, 3:00 PM CST

-16.09% (1Y)

Market Cap	7.20B -7.7%
Revenue (ttm)	3.25B -5.0%
Net Income	299.79M -11.8%
EPS	0.53 -8.7%
Shares Out	566.16M
PE Ratio	23.99
Forward PE	21.02
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,757,000
Open	12.60
Previous Close	12.61
Day's Range	12.43 - 12.81
52-Week Range	10.69 - 20.20
Beta	0.45
Analysts	Strong Buy
Price Target	15.66 (+23.11%)
Earnings Date	Aug 28, 2026

About SHA:600557

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 and is based in Lianyungang, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1975

Employees 5,379

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600557

Full Company Profile

Financial Performance

In 2025, SHA:600557's revenue was 3.29 billion, a decrease of -15.52% compared to the previous year's 3.90 billion. Earnings were 303.93 million, a decrease of -22.44%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 600557 stock is "Strong Buy." The 12-month stock price target is ¥15.66, which is an increase of 23.11% from the latest price.

Price Target

¥15.66

(23.11% upside)

Analyst Consensus: Strong Buy

Stock Forecasts